Bright light and exercise program for people with lung or esophageal cancer
Tests bright light exposure with exercise in adults with lung or esophageal cancer.
Key facts
- Who runs it
- Taipei Veterans General Hospital, Taiwan
- Where
- Taipei and Taipei City, TaiwanSee the 2 sites
- Trial code
- Registry title
- Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 24 Jul 2023
- Expected to end
- 15 May 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Daylight exposure combine walking
- Stretching exercise
- Record updated
- 17 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with newly diagnosed lung or esophageal cancer, stage 1 to 3, who are in hospital for surgery to remove the cancer.
- Age
- At least 20 years old.
- Sex
- All sexes can join.
- Disease stage
- Newly diagnosed primary lung cancer or esophageal cancer, from the first stage to the third stage.
- Earlier treatment
- Must be in hospital for surgery to remove the lung or esophageal cancer lesion.
Main reasons for not taking part
- Congestive heart failure
- Bone or joint disease of the legs that limits walking
- Cannot communicate in Mandarin Chinese or Taiwanese
- Cannot read, or has cognitive disabilities
- Karnofsky Performance Scale score below 70 points
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patients with newly diagnosed primary lung cancer or esophageal cancer, from the first stage to the third stage
- At least 20 years of age
- Able to communicate in Mandarin Chinese or Taiwanese
- Literate and free from cognitive disabilities
- The attending physician agrees to participate in the study
- Those who can connect to the Internet with mobile devices such as computers, mobile phones, and tablets, or those whose family members can assist in the operation
- Those with Karnofsky Performance Scale (KPS) greater than or equal to 70 points
- Those who are hospitalized for lung cancer or esophageal cancer lesion resection
Who cannot take part
- Congestive heart failure
- Orthopedic diseases of the lower extremities that limit one's walking ability
Where in Taiwan
- Taipei Medical University HospitalTaipei, TaiwanContact: Hui-Mei Chen, PhDTaking people
- Taipei Veterans General HospitalTaipei City, TaiwanContact: Hui-Mei Chen, PhDTaking people
About the trial
What the trial wants to find out
This study plans to investigate the effectiveness of six-week light exposure combined with an exercise training program on improving sleep-wake rhythm, physical and mental symptoms, quality of life, one-year recurrence rate, and one-year survival rate of patients with lung and esophageal cancer.
The 2 groups in the trial
- Experimental groupTreatment being tested
The rehabilitation program is composed of two parts: six-week bright-light exposure program and an exercise program.
Treatment: Daylight exposure combine walking
- Active control groupExisting treatment, for comparison
The active control group receives six weeks of a stretching exercise.
Treatment: Stretching exercise
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program on Sleep-Wake Rhythm, Physical and Psychological Symptoms, and Quality of Life of Patients With Thoracic Cancer: A Series Study.
- Plain-language title
- Bright light and exercise program for people with lung or esophageal cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 17 February 2026